TOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake sale
On completion, Pfizer, the New York-based pharmaceuticals firm, will see its interest in Haleon fall to just over 16% from 22.6% currently. Bloomberg reported that the share sale price is likely to be 380 pence per share, raising around GBP2.7 billion.
Haleon to Increase Stake in China JV to 88%
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, ...
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
From US drugmaker Pfizer's stake sale in Sensodyne maker Haleon to Beijing joining the list of Chinese cities easing ...
According to the woman, her teeth were prone to damage and breaking, making it nearly impossible for her to brush her teeth.
DoctorsOfJoy aims to highlight how dentists empower individuals to fully enjoy life's moments by addressing oral health ...
Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...
Indian banks' loan growth moderated in August amid a slowdown in credit card debt and personal loans, central bank data ...
Pfizer Inc. announced a further reduction of its stake in Haleon Plc, offering to sell about a 5.9% stake in the UK consumer ...
Sensitive care toothpaste brand Sensodyne has launched an all-in-one care toothpaste 'Sensodyne Complete Protection Plus'.It ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback